Articles


  views (11585)
Open Access

Aprile G, Macerelli M, De Maglio G, Pizzolitto S, Fasola G. The relevance of BRAF and extended RAS mutational analyses for metastatic colorectal cancer patients. OA Molecular Oncology 2013 Dec 25;1(1):7.


  views (10966)
Open Access

Cerezo-Manchado JJ, Romera M, Gallego P, Rold?n V. Are biomarkers useful in thrombotic risk assessment in oncologic patients? OA Molecular Oncology 2013 Mar 01;1(1):4.


  views (10497)
Open Access

Bollig-Fischer A, Michelhaugh SK, Ali-Fehmi R, Mittal S. The molecular genomics of metastatic brain tumours OA Molecular Oncology 2013 Apr 01;1(1):6.


  views (10341)
Open Access

Van Dyke MW, Nelson LD. Triple helix-interacting proteins and cancer. OA Molecular Oncology 2013 Apr 01;1(1):5.


  views (7969)
Open Access

Musto A, Chondrogiannis S, Ferretti A, Crepaldi G, Marzola MC, Rampin L, Pasini F, Rubello D. 18F-FDG PET/CT may detect early response to Imatinib mesylate in GISTs with exon 11 mutation: case report and critical review of literature. OA Molecular Oncology 2013 Feb 01;1(1):1.


  views (6849)
Open Access

Hartwig FP. A probe-based alternative method for allele-specific amplification for targeted haplotyping. OA Molecular Oncology 2013 Mar 01;1(1):3.


  views (6833)
Open Access

Jovanović KK, Savić AG, Krivokuća AM, Janković R. Differential response to targeted therapy in non-small cell lung carcinoma patients harbouring epidermal growth factor receptor mutations-a demand for diagnostic procedure optimization-a critical review. OA Molecular Oncology 2013 Feb 01;1(1):2.


  views (6573)
Open Access

Lai S, Oseran A, Marshall J. Molecular biomarkers in colorectal cancer in pursuit of personalizing treatment. OA Molecular Oncology 2014 Jan 18;2(1):1.